Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07635940 · ClinicalTrials.gov registry record · NA

Effects of Transcranial Magnetic Stimulation on Social Cognition, Cognitive Processing, and Functional Brain Architecture

A NA study, sponsored by University of Colorado, Denver.

Not yet
Registry status
NA
Development phase
60
Enrollment target

NCT07635940 is a NA study that has not yet begun recruiting, run by University of Colorado, Denver. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07635940, a NA study, has not yet begun recruiting, sponsored by University of Colorado, Denver.

NOT YET RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This clinical trial will examine whether transcranial magnetic stimulation (TMS), a noninvasive form of brain stimulation, can influence social cognition, cognitive processing, and brain function in adults with elevated psychopathic traits. The study will also evaluate the safety and feasibility of delivering TMS in this population. Participants will be randomly assigned to receive either active TMS or sham (placebo-like) TMS. The study will compare outcomes between participants receiving active versus sham TMS and will evaluate changes from before to after TMS exposure. Participants will: * Complete a baseline magnetic resonance imaging (MRI) brain scan. * Receive three single-session TMS interventions. * Complete a post-intervention MRI brain scan. * Complete assessments of social cognition. * Complete assessments of cognitive processing. The primary objectives are to determine whether TMS can influence social cognition, cognitive processing, and functional brain organization and connectivity in adults with elevated psychopathic traits.

Interventions

  • DEVICE continuous theta burst stimulation (cTBS)
  • DEVICE Sham
  • DEVICE Intermittent theta burst stimulation (iTBS)

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-06
Est. Completion 2030-08
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT07635940

The ClinicalTrials.gov registry entry for NCT07635940 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which continuous theta burst stimulation (cTBS) is the first listed.

NCT07635940 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07635940 about?

NCT07635940 is a clinical study titled "Effects of Transcranial Magnetic Stimulation on Social Cognition, Cognitive Processing, and Functional Brain Architecture". This clinical trial will examine whether transcranial magnetic stimulation (TMS), a noninvasive form of brain stimulation, can influence social cognition, cognitive processing, and brain function in adults with elevated psychopathic traits. The study will also evaluate the safety and feasibility of ...

What is the current status of trial NCT07635940?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-06. Estimated completion is 2030-08.

What interventions are being tested in trial NCT07635940?

The interventions under investigation include: continuous theta burst stimulation (cTBS) (DEVICE), Sham (DEVICE), Intermittent theta burst stimulation (iTBS) (DEVICE).

Who is sponsoring clinical trial NCT07635940?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.